North Star Investment Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.9K | Buy |
121
+33
| +38% | +$3.03K | ﹤0.01% | 1009 |
|
|
2025
Q4 | $7.91K | Sell |
88
-172
| -66% | -$16.3K | ﹤0.01% | 1003 |
|
|
2025
Q3 | $25.6K | Hold |
260
| – | – | ﹤0.01% | 780 |
|
|
2025
Q2 | $23.7K | Hold |
260
| – | – | ﹤0.01% | 764 |
|
|
2025
Q1 | $29.4K | Hold |
260
| – | – | ﹤0.01% | 707 |
|
|
2024
Q4 | $27.5K | Hold |
260
| – | – | ﹤0.01% | 714 |
|
|
2024
Q3 | $28.1K | Sell |
260
-115
| -31% | -$12.6K | ﹤0.01% | 682 |
|
|
2024
Q2 | $40.7K | Sell |
375
-294
| -44% | -$34.7K | ﹤0.01% | 626 |
|
|
2024
Q1 | $88.2K | Buy |
669
+95
| +17% | +$11.9K | 0.01% | 527 |
|
|
2023
Q4 | $69.9K | Sell |
574
-9
| -2% | -$1K | 0.01% | 544 |
|
|
2023
Q3 | $65.4K | Hold |
583
| – | – | 0.01% | 549 |
|
|
2023
Q2 | $84.9K | Hold |
583
| – | – | 0.01% | 526 |
|
|
2023
Q1 | $75.3K | Buy |
583
+1
| +0.2% | +$126 | 0.01% | 553 |
|
|
2022
Q4 | $74.3K | Buy |
582
+9
| +2% | +$1.04K | 0.01% | 531 |
|
|
2022
Q3 | $60K | Hold |
573
| – | – | 0.01% | 510 |
|
|
2022
Q2 | $60K | Hold |
573
| – | – | 0.01% | 523 |
|
|
2022
Q1 | $73K | Sell |
573
-51
| -8% | -$6.15K | 0.01% | 514 |
|
|
2021
Q4 | $77K | Buy |
624
+35
| +6% | +$4.58K | 0.01% | 528 |
|
|
2021
Q3 | $84K | Hold |
589
| – | – | 0.01% | 502 |
|
|
2021
Q2 | $92K | Hold |
589
| – | – | 0.01% | 494 |
|
|
2021
Q1 | $92K | Hold |
589
| – | – | 0.01% | 462 |
|
|
2020
Q4 | $88K | Hold |
589
| – | – | 0.01% | 453 |
|
|
2020
Q3 | $78K | Buy |
589
+1
| +0.2% | +$131 | 0.01% | 446 |
|
|
2020
Q2 | $68K | Hold |
588
| – | – | 0.01% | 448 |
|
|
2020
Q1 | $58K | Hold |
588
| – | – | 0.01% | 463 |
|
|
2019
Q4 | $85K | Hold |
588
| – | – | 0.01% | 458 |
|
|
2019
Q3 | $78K | Buy |
+588
| New | +$76K | 0.01% | 469 |
|
|
2019
Q2 | – | Sell |
-587
| Closed | -$73K | – | 959 |
|
|
2019
Q1 | $73K | Hold |
587
| – | – | 0.01% | 493 |
|
|
2018
Q4 | $59K | Hold |
587
| – | – | 0.01% | 491 |
|
|
2018
Q3 | $75K | Buy |
587
+113
| +24% | +$13.4K | 0.01% | 489 |
|
|
2018
Q2 | $51K | Hold |
474
| – | – | 0.01% | 555 |
|
|
2018
Q1 | $50K | Hold |
474
| – | – | 0.01% | 562 |
|
|
2017
Q4 | $56K | Hold |
474
| – | – | 0.01% | 523 |
|
|
2017
Q3 | $54K | Hold |
474
| – | – | 0.01% | 536 |
|
|
2017
Q2 | $59K | Hold |
474
| – | – | 0.01% | 510 |
|
|
2017
Q1 | $56K | Hold |
474
| – | – | 0.01% | 506 |
|
|
2016
Q4 | $47K | Hold |
474
| – | – | 0.01% | 508 |
|
|
2016
Q3 | $60K | Hold |
474
| – | – | 0.01% | 391 |
|
|
2016
Q2 | $55K | Hold |
474
| – | – | 0.01% | 398 |
|
|
2016
Q1 | $49K | Hold |
474
| – | – | 0.01% | 405 |
|
|
2015
Q4 | $47K | Sell |
474
-4
| -0.8% | -$391 | 0.01% | 404 |
|
|
2015
Q3 | $44K | Hold |
478
| – | – | 0.01% | 411 |
|
|
2015
Q2 | $51K | Hold |
478
| – | – | 0.01% | 391 |
|
|
2015
Q1 | $55K | Sell |
478
-206
| -30% | -$23.5K | 0.01% | 372 |
|
|
2014
Q4 | $75K | Buy |
684
+618
| +936% | +$65.1K | 0.01% | 348 |
|
|
2014
Q3 | $6K | Hold |
66
| – | – | ﹤0.01% | 566 |
|
|
2014
Q2 | $7K | Sell |
66
-15
| -19% | -$1.46K | ﹤0.01% | 596 |
|
|
2014
Q1 | $7K | Buy |
+81
| New | +$7.46K | ﹤0.01% | 574 |
|
Other funds holding ZBH
VCM
VPM
North Star Investment Management's ZBH Position: Q1 2026 in Review
North Star Investment Management increased its Zimmer Biomet (ZBH) stake by 38% in Q1 2026, buying an estimated $3.03K and bringing the position to 121 shares worth $10.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1009.
North Star Investment Management first reported a position in ZBH in Q1 2014 and has held it in 48 quarters since. The position peaked at $92K in Q2 2021. 914 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- North Star Investment Management held 121 shares of Zimmer Biomet worth $10.9K as of Q1 2026.
- North Star Investment Management bought 33 Zimmer Biomet shares in Q1 2026, an estimated $3.03K.
- Zimmer Biomet made up ﹤0.01% of North Star Investment Management's portfolio in Q1 2026, its #1009 holding.
- North Star Investment Management first reported a position in Zimmer Biomet in Q1 2014 and has held it in 48 quarters since.
- North Star Investment Management's Zimmer Biomet position peaked at $92K in Q2 2021.
- 914 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on North Star Investment Management's 13F filing for Q1 2026, filed 23 Apr 2026.